|
|
 |
 |
 Satellite
Symposia |
Wednesday | April
25, 2007 |
Lunchtime Activities
12:30 PM-1:30 PM |
#1.The Next Generation DES
Coronary Arena, Level 1
Co-sponsored by St. Jude Medical Korea |
Moderators: Mitchell W. Krucoff,
MD, Roxana Mehran, MD
Panelists: Kyoo-Rok Han, MD, Shigeru Saito, MD, Seung-Jea Tahk, MD |
| 12:30 PM |
Welcome Address & Introduction
of Penalists |
Mitchell W. Krucoff, MD |
| 12:35 PM |
The Conor Technology |
Mitchell W. Krucoff, MD |
| 12:55 PM |
The
CoStar Clinical Data  |
Roxana Mehran, MD |
| 1:15 PM |
Discussion, Q & A |
|
| 1:25 PM |
Closing Remark |
Roxana Mehran, MD |
| 1:30 PM |
Adjourn |
|
| |
|
|
#2. Antiplatelet Therapy
for Atherothrombotic Disease
Symposium Arena, Level 1
Sponsored by Bristol-Myers Squibb Korea & Sanofi-Aventis Korea
Co., Ltd. |
| Moderator: Dong Joo Oh, MD |
| 12:30 PM |
Welcome Address |
Dong Joo Oh, MD |
| 12:35 PM |
Dual
Antiplatelet Therapy: How Long Should It Be Continued after DES Implantation?
|
Cheol Whan Lee, MD |
| 1:00 PM |
ISAR-CHOICE-2:
Randomized Trial of 75 mg vs 150 mg of Daily Clopidogrel in Patients
Undergoing PCI |
Adnan Kastrati, MD |
| 1:25 PM |
Q & A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#3. Novel Insights, New Directions:
Bivalirudin Trials
Room 2-1
Sponsored by Asia Pharm.Ind.Co.,Ltd. |
| Moderators: Seung-Jung Park, MD,
Gregg W. Stone, MD |
| 12:30 PM |
Welcome Address |
Seung-Jung Park, MD |
| 12:35 PM |
Pushing
the Envelope for Bivalirudin Monotherapy: Design, Rationale, and Status
of ISARREACT-4 and HORIZONS |
Adnan Kastrati, MD |
| 12:50 PM |
Bivalirudin
for the Best Overall Outcomes and Most Cath Lab Compatible |
Gregg W. Stone, MD |
| 1:05 PM |
Direct
Thrombin Inhibitors for PCI Pharmacology: Role of Bivalirudin in High
Risk PCI |
Charles A. Simonton, MD |
| 1:20 PM |
Q & A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#4. Angiomyogenesis Symposium
Room 2-2
Sponsored by CardioVascular Research Foundation(CVRF) |
| Moderator: Dong Ju Choi, MD |
| 12:30 PM |
Welcome Address |
Dong Ju Choi, MD |
| 12:35 PM |
Stem Cell Biology for Vascular Medicine |
Takayuki Asahara, MD |
| 1:00 PM |
Stem
Cell Therapy for Ischemic Heart Disease - What Do We Know from Clinical
Trials? |
Birgit Assmus, MD |
| 1:25 PM |
Q & A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#5. Recent Advances in the
Fight Against Atherosclerosis
Room 3-1
Sponsored by AstraZeneca Korea |
| Moderator: Ki Bae Seung, MD |
| 12:30 PM |
Effects
of Statin Therapy on Ruptured Coronay Plaque |
Myeong-Ki Hong, MD |
| 12:55 PM |
Q & A |
|
| 1:00 PM |
Arterial
Wall Remodeling in Response to Atheroma Regression with Very Intensive
Lipid Lowering |
Matthew Worthley, MD |
| 1:25 PM |
Q & A |
|
| |
|
|
#6. Achieving the Higher
Standard in the Management of Hypertension and Hypercholesterolemia
Room 4-1
Sponsored by MSD Korea |
| Moderator: Jae-Joong Kim, MD |
| 12:30 PM |
Welcome Address |
|
| 12:40 PM |
Optimizing
the Treatment for Hypertensive Patients Led by Evidence: Is It All
about Blood Pressure? |
Jeong Bae Park, MD |
| 1:00 PM |
Achieving
the Superior Treatment Goal for Patients at Risks Through Powerful
Inhibition of Two Sources of Cholesterol -"VYTAL Study"
|
Szilard Voros, MD |
| 1:20 PM |
Q & A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#7. Oral Abstract Presentations
- Best Abstracts
Room 2-3
Sponsored by CardioVascular Research Foundation(CVRF) |
| Moderators: Alexandra J. Lansky,
MD, Alan C. Yeung, MD |
| 12:30 PM |
AS-13, Triple Antiplatelet Therapy Enhanced a
Platelet Inhibition by Clopidogrel More Than Dual Antiplatelet Therapy
after Drug-Eluting Stent Implantation: Insights from the Clopidogrel
and Aspirin Resistance Evaluation in Patients undergoing Coronary
Revascularization (CARE-PCR) Registry |
Seong-Wook Park, MD |
| 12:42 PM |
AS-9, Predictors of Irreversible Events after
Percutaneous Coronary Intervention of Unprotected Left Main Lesions |
Helen Routledge, MD |
| 12:54 PM |
AS-8, Is the Routine Use of Thrombectomy and
Distal Protection Devices of Clinical Benefit in Acute Myocardial
Infarction? A Meta-Analysis |
Monica Masotti, MD |
| 1:06 PM |
AS-10, A Stent Fracture and Restenosis of a Sirolimus-Eluting
Stent in the Real World |
Takeshi Serikawa, MD |
| 1:18 PM |
AS-16, Assessment of Coronary Yellow and White
Plaque by Optical Coherence Tomography: Comparison with Coronary Angioscopic
Image |
Hironori Kitabata, MD |
| 1:30 PM |
Adjourn |
|
| |
|
|
Evening Satellite Symposia
6:00 PM-9:00 PM |
#1. DES Safety and Efficacy
: The Endeavor Perspective
Coronary Arena, Level 1
Co-sponsored by Medtronic, Inc. |
Moderators: Myeong-Ki Hong, MD, Alan
C. Yeung, MD
Panelists: In-Ho Chae, MD, Charles Chan, MD, Kai Huat Lam, MD, Chong-Jin
Kim, MD |
| 6:00 PM |
Dinner Reception & Welcome Address |
|
| 6:30 PM |
Endeavor
Clinical Program Overview |
Marco A. Costa, MD |
| 6:50 PM |
Endeavor
- Combining Safety with Efficacy |
Eulogio Garcia, MD |
| 7:10 PM |
What
Makes Endeavor Different |
Alan C. Yeung, MD |
| 7:30 PM |
DES
Safety Concerns: Impact on Clinical Practice |
Martin B. Leon, MD |
| 7:50 PM |
Q & A |
|
| 8:00 PM |
Adjourn |
|
| |
|
|
#2. What is Your Vision of
DES Performance?
Symposium Arena, Level 1
Co-sponsored by Abbott Vascular |
Moderators: Jeong Euy Park, MD, Gregg
W. Stone, MD
Panelists: Dong Hoon Choi, MD, Seung-Ho Hur, MD, Moo Hyun Kim, MD,
Tarlochan Singh Kler, MD, Michael Kang-Yin Lee, MD |
| 6:00 PM |
Dinner Reception & Welcome Address |
Jeong Euy Park, MD |
| 6:30 PM |
SPIRIT
III (US Pivotal Study Results for Xience V Everolimus Eluting Coronary
Stent) |
Gregg W. Stone, MD |
| 7:00 PM |
The
Science Behind Xience V |
Jacques J. Koolen, MD |
| 7:30 PM |
ABSORB (Six Month Results from World's First
Clinical Trial of a Fully Bioabsorbable DES) |
John Ormiston, MD |
| 8:00 PM |
Q & A with Panel Discussion |
|
| 8:30 PM |
Adjourn |
|
| |
|
|
#3. TAXUS - Proven Safety
& Best Practice in DES
Room 3-1, Level 3
Co-sponsored by Boston Scientific Korea |
Moderators: Antonio Colombo, MD,
Seong-Wook Park, MD
Panelists: Tae-Hoon Ahn, MD, Yang-Soo Jang, MD, Myung-Ho Jeong, MD,
Joerg Koglin, MD, Thierry Lefévre, MD, Hun-Shik Park, MD, In-Hwan
Seong, MD, Seung-Jae Tahk, MD |
| 6:00 PM |
Opening Remark & Welcome Address |
Seong-Wook Park, MD
Antonio Colombo, MD |
| 6:10 PM |
Better
Diabetic Performance in TAXUS |
Antonio Colombo, MD |
| 6:40 PM |
Bifurcations
and Left Main with TAXUS |
Thierry Lefevre, MD |
| 7:10 PM |
TAXUS
Clinical Result Updates & Future Pipeline |
Joerg Koglin, MD |
| 7:40 PM |
IVUS
Roles and Benefits in DES Era |
Seung-Jae Tahk, MD |
| 8:10 PM |
Q & A with Panel Discussion |
|
| 8:30 PM |
Adjourn |
|
| |
|
|
#4. Coronary Drug Eluting
Stent: Safety, Efficacy and Future Innovations
Room 4-1, Level 4
Co-sponsored by Johnson & Johnson Medical Korea |
Co-Moderators: David Kandzari, MD,
Seung-Jung Park, MD
Panelists: Myeong-Chan Cho, MD, Hyeon Cheol Gwon, MD, Do Sun Lim,
MD, Ki Bae Seung, MD, Junghan Yoon, MD |
| 6:00 PM |
Welcome Address |
Seung-Jung Park, MD |
| 6:10 PM |
Addressing
the Controversy of Late DES Thrombosis |
Martin B. Leon, MD |
| 6:40 PM |
Cypher
in Complex Lesion |
Alexandre Abizaid, MD |
| 7:10 PM |
Long-Term
Evaluation of DES vs. BMS; 10-Year Experience from Single Center Registry
|
Seung-Jung Park, MD |
| 7:40 PM |
Future
Technologies from Cordis |
David Kandzari, MD |
| 8:10 PM |
Q&A with Panel Discussion |
|
| 8:30 PM |
Adjourn |
|
|
|
Thursday | April 26, 2007 |
Lunchtime Activities
12:30 PM-1:30 PM |
#8. Trends & Futures
in Endovascular Treatment - SFA & BTK
Coronary Arena, Level 1
Sponsored by Johnson & Johnson Medical Korea |
| Moderator: Michael R. Jaff, MD, Seong-Wook
Park, MD |
| 12:30 PM |
Welcome Address |
Seong-Wook Park, MD |
| 12:32 PM |
PVD
Diagnostics & Screening: What Are the Options for Treatment?
|
Michael R. Jaff, MD |
| 12:45 PM |
Trends
in Endovascular Procedures on Lower Extremity |
Michael R. Jaff, MD |
| 1:00 PM |
BTK Treatment Option: Complex PTA or Stenting? |
Dierk Scheinert, MD |
| 1:25 PM |
Q & A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#9. First Do No Harm, The
Role of Pro-Healing Genous Stent
Symposium Arena, Level 1
Sponsored by OrbusNeich Medical Korea, Ltd |
| Moderator: Seung-Jung Park, MD |
| 12:30 PM |
Welcome Address |
Seung-Jung Park, MD |
| 12:35 PM |
Endothelial
Progenitor Cell Capture Technology and Beyond |
Michael J.B. Kutryk, MD |
| 12:50 PM |
Real World Experience with Genous: The E-Healing
Registry |
Michael J.B. Kutryk, MD |
| 1:05 PM |
Healing
AMI |
Harry Suryapranata, MD |
| 1:20 PM |
Q&A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#10. The Optimal Therapeutic
Approach for the Management of Metabolic Disorder
Room 2-1
Sponsored by NOVARTIS Korea Ltd. |
| Moderators: Yang-Soo Jang, MD, Chang
Kyu Park, MD |
| 12:30 PM |
Welcome Address |
Yang-Soo Jang, MD |
| 12:32 PM |
The
Road to Renin System Optimization; From ARB to Direct Renin Inhibition
|
Yong Jin Kim, MD |
| 12:52 PM |
Role
of Statin: Optimal Treatment for PCI Patients
|
Sang Hak Lee, MD |
| 1:12 PM |
Emerging
Type 2 Diabetes Therapies: Potential of the New DPP-4 Inhibitors
|
Ki Hoon Han, MD |
| 1:30 PM |
Adjourn |
|
| |
|
|
#11. New Insights into Atherosclerosis:
Evidence Based Outcomes
Room 3-1
Sponsored by Pfizer Pharmaceutical Korea Ltd. |
| Moderator: Jae-Joong Kim, MD |
| 12:30 PM |
Welcome Address |
|
| 12:35 PM |
In-Depth
Review of CV Outcomes Through Statin Treatment Based on ALPS |
Dong Ju Choi, MD |
| 1:00 PM |
Share Your Vision With Lipitor |
|
| 1:25 PM |
Closing Remark |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#12. Principles and Insights
from Optical Coherent Tomography Imaging System
Room 4-1
Sponsored by Focusmedical Co., Ltd, Goodman Korea, LightLab Imaging,
Inc. |
Moderators: Ik-Kyung Jang, MD, Seung-Jea
Tahk, MD
Panelists: Takashi Akasaka, MD, In-Ho Chae, MD, Chong-Jin Kim, MD,
Mitsuyasu Terashima, MD |
| 12:30 PM |
Welcome Address |
Seung-Jea Tahk, MD |
| 12:35 PM |
Assessment
of Plaque Morphology by OCT in Patients with Acute Coronary Syndrome
|
Takashi Akasaka, MD |
| 12:55 PM |
The Relationship Between Coronary Artery Remodeling
and Plaque Characteristic |
Ik-Kyung Jang, MD |
| 1:15 PM |
Q & A |
|
| 1:30 PM |
Adjourn |
|
| |
|
|
#13. Oral Abstract Presentations
- Best Abstracts
Room 2-3
Sponsored by CardioVascular Research Foundation(CVRF) |
| Moderators: Mun Kyung Hong, MD, Charles
A. Simonton, MD |
| 12:30 PM |
AS-11, Results and Predictors of Angiographic
Restenosis and Long-Term Adverse Cardiac Events After Drug-Eluting
Stent Implantation for Aorto-Ostial Coronary Artery Disease |
Duk Woo Park, MD |
| 12:42 PM |
AS-3, Multislice Cardiac Computed Tomography
Imaging of Patients Undergoing Percutaneous Aortic Valve Replacement
(Core Valve) |
Anita W. Asgar, MD |
| 12:54 PM |
AS-12, Drug-Eluting Sents for the Treatment of
Left Main Bifurcation Stenosis in the Elderly Patients |
Teguh Santoso, MD |
| 1:06 PM |
AS-7, Clinical Characteristics and Interventional
Management of Patients with Acute or Subacute Coronary In-stent Thrombosis |
Yaling Han, MD |
| 1:18 PM |
AS-15, A Comparison of Clinical Characteristics
of Stent Thrombosis in Time Period and Early vs Late Stent Thrombosis |
Seok- Jae Hwang, MD |
| 1:30 PM |
Adjourn |
|
|
|
|
summitMD.com
